{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69cbcfb74bc3c0b5cea89f0c/6accaa44f38f25c0f0f59d06?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Safety and Effectiveness of the Vertex Pulmonary Embolectomy System in Acute Intermediate-Risk Pulmonary Embolism: SPIRARE II Pivotal Trial","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69cbcfb74bc3c0b5cea89f0c/1791797814466-47835329-cc32-4a86-907a-5c6d50ae522d.jpeg?height=200","description":"<p>In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Catalin Toma dive into the findings of SPIRARE II.</p><p> Dr Toma shares the strategy behind enriching the trial&#39;s design; core efficacy and safety endpoint results (RV/LV ratio &amp; MAE rates); the mechanics and potential advantages of the Vertex technology; and future clinical horizons for mechanical thrombectomy.</p>","author_name":"EuroIntervention"}